These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 18173026)

  • 21. Incidence of Parkinson's disease in Singapore.
    Tan LC; Venketasubramanian N; Jamora RD; Heng D
    Parkinsonism Relat Disord; 2007 Feb; 13(1):40-3. PubMed ID: 17055328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of movement disorders in an elderly nursing home population.
    Tse W; Libow LS; Neufeld R; Lesser G; Frank J; Dolan S; Tarshish C; Gracies JM; Olanow CW; Koller WC; Hälbig TD
    Arch Gerontol Geriatr; 2008; 46(3):359-66. PubMed ID: 17597235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is there seasonal variation in risk of Parkinson's disease?
    Postuma RB; Wolfson C; Rajput A; Stoessl AJ; Martin WR; Suchowersky O; Chouinard S; Panisset M; Jog MS; Grimes DA; Marras C; Lang AE
    Mov Disord; 2007 Jun; 22(8):1097-101. PubMed ID: 17486603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of Parkinson's disease in entrants on the Nebraska State Parkinson's Disease Registry.
    Bertoni JM; Sprenkle PM; Strickland D; Noedel N
    Mov Disord; 2006 Oct; 21(10):1623-6. PubMed ID: 16874754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of major neurological disorders among geriatric population in the metropolitan city of Kolkata.
    Das SK; Biswas A; Roy J; Bose P; Roy T; Banerjee TK; Mukherjee C; Raut DK; Chowdhury A; Hazra A
    J Assoc Physicians India; 2008 Mar; 56():175-81. PubMed ID: 18697633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Case ascertainment uncertainties in prevalence surveys of Parkinson's disease.
    Anderson DW; Rocca WA; de Rijk MC; Grigoletto F; Melcon MO; Breteler MM; Maraganore DM
    Mov Disord; 1998 Jul; 13(4):626-32. PubMed ID: 9686765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mental health care use in Parkinson's disease: a record linkage study.
    Leentjens AF; Driessen G; Weber W; Drukker M; van Os J
    Neuroepidemiology; 2008; 30(2):71-5. PubMed ID: 18277080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does a vegan diet reduce risk for Parkinson's disease?
    McCarty MF
    Med Hypotheses; 2001 Sep; 57(3):318-23. PubMed ID: 11516224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epilepsy and epileptic disorders, an epidemiological marker? Contribution of descriptive epidemiology.
    Jallon P
    Epileptic Disord; 2002 Mar; 4(1):1-13. PubMed ID: 11967174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parkinson's disease dementia: definitions, guidelines, and research perspectives in diagnosis.
    Goetz CG; Emre M; Dubois B
    Ann Neurol; 2008 Dec; 64 Suppl 2():S81-92. PubMed ID: 19127578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in prevalence and incidence of Parkinson's disease in Japan during a quarter of a century.
    Yamawaki M; Kusumi M; Kowa H; Nakashima K
    Neuroepidemiology; 2009; 32(4):263-9. PubMed ID: 19209006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent trends in coronary heart disease epidemiology in India.
    Gupta R
    Indian Heart J; 2008; 60(2 Suppl B):B4-18. PubMed ID: 19359764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive impairment in Parkinson's disease: tools for diagnosis and assessment.
    Kulisevsky J; Pagonabarraga J
    Mov Disord; 2009 Jun; 24(8):1103-10. PubMed ID: 19353727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Depression in Parkinson's disease. Part 1: epidemiology, signs and symptoms, pathophysiology and diagnosis].
    Storch A; Ebersbach G; Fuchs G; Jost WH; Odin P; Reifschneider G; Bauer M
    Fortschr Neurol Psychiatr; 2008 Dec; 76(12):715-24. PubMed ID: 19012223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathogenesis of familial Parkinson's disease: new insights based on monogenic forms of Parkinson's disease.
    Hatano T; Kubo S; Sato S; Hattori N
    J Neurochem; 2009 Dec; 111(5):1075-93. PubMed ID: 19780902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The pathogenesis of Parkinson's disease: a hint from insights of familial Parkinson's disease].
    Hattori N; Kubo S
    Rinsho Shinkeigaku; 2007 Nov; 47(11):774-8. PubMed ID: 18210796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of chronic analgesic drugs prevalence in Parkinson's disease, other chronic diseases and the general population.
    Brefel-Courbon C; Grolleau S; Thalamas C; Bourrel R; Allaria-Lapierre V; Loï R; Micallef-Roll J; Lapeyre-Mestre M
    Pain; 2009 Jan; 141(1-2):14-8. PubMed ID: 19062167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Projected numbers of people with movement disorders in the years 2030 and 2050.
    Bach JP; Ziegler U; Deuschl G; Dodel R; Doblhammer-Reiter G
    Mov Disord; 2011 Oct; 26(12):2286-90. PubMed ID: 22021158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced NADH coenzyme Q dehydrogenase activity in platelets of Parkinson's disease, but not Parkinson plus patients, from an Indian population.
    Varghese M; Pandey M; Samanta A; Gangopadhyay PK; Mohanakumar KP
    J Neurol Sci; 2009 Apr; 279(1-2):39-42. PubMed ID: 19176229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biomarkers for Parkinson's [corrected] disease: tools to assess Parkinson's disease onset and progression.
    Marek K; Jennings D; Tamagnan G; Seibyl J
    Ann Neurol; 2008 Dec; 64 Suppl 2():S111-21. PubMed ID: 19127587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.